Moderna COVID-19 shot recommended in Europe as booster for adolescents
Maddie Meyer/Getty Images News


The European Medicines Agency (EMA) announced on Friday that its Committee for Medicinal Products for Human Use (CHMP) endorsed the use of the Moderna (NASDAQ:MRNA) COVID-19 vaccine as a booster shot for those aged 12 to 17 years.

CHMP has also recommended an update to the product information of the vaccine, branded as Spikevax in the region, to reflect that shot remains stable for 12 months under certain conditions.
Additionally, the committee greenlighted the approval of a new manufacturing site for the vaccineâs finish product in Madrid, Spain.
The CHMP recommendation on Moderna (MRNA) booster comes about a year after it was cleared in the region as a primary series in adolescents. 
The U.S. regulators cleared the vaccine for children and adolescents aged 6 â 17 years last month after a months-long delay amid concerns over rare cases of heart inflammation.